Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers.

Wanting ShaoChristina KuhnDoris MayrNina DitschMagdalena KailuwaitVerena WolfNadia HarbeckSven MahnerUdo JeschkeVincent CavaillèsSophie Sixou

Published in: Journal of translational medicine (2020)

Altogether, these data suggest that the relative expression of cytoplasmic PPARγ and Cox-1 may play an important role in oncogenesis and could be defined as a potential prognosis marker to identify specific high risk BC subgroups.

Keyphrases

poor prognosis
long non coding rna
insulin resistance
electronic health record
fatty acid
big data
metabolic syndrome
type diabetes
machine learning
risk assessment
data analysis
artificial intelligence
childhood cancer